Back

Lecture - Risk stratification in DCM/NDLVC

28 November 2025 (12:30 - 12:50)
Organised by: Logo
Seminar Presentation Part of: SESSION IV - TTR-related Cardiac amyloidosis: therapeutic challenges (joint with HFA Cardiac Amyloidosis Committee) Pericardial Disease, Other Open Access M&PD Annual meeting 2025 WG on Myocardial and Pericardial Diseases

About the speaker

Photo
Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Heart failure therapies: focus on MRAs/K binders and SGLT2i
Doctor A. Porcari (London, GB)
Presentation thumbnail
Real-world data
Doctor F. Cappelli (Florence, IT)
Slides
Presentation thumbnail
Specific therapy: tafamidis, acoramidis, what else?
Mr P. Garcia Pavia (Madrid, ES)
Slides
Presentation thumbnail
Stabilizers, Gene silencing/editing, Depletors: how can we select the best candidates?
Professor M. Emdin (Pisa, IT)

Access the full session

Session thumbnail
SESSION IV - TTR-related Cardiac amyloidosis: therapeutic challenges (joint with HFA Cardiac Amyloidosis Committee)

The Event

Event poster

M&PD Annual meeting 2025

28 November 2025 12:30 CET
You may be interested in
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
31 March 2025
thumbnail
Congress Presentation
Prognostic impact of the concept of late gadolinium enhancement granularity in non-ischaemic dilated cardiomyopathy
2 September 2024
thumbnail
Congress Session
Young Investigator Award (YIA) Clinical Cardiology
18 May 2025
thumbnail
Webinar
Sudden cardiac death risk stratification in cardiomyopathies. ESC 2023 Clinical Practice Guidelines - Webinar Series
11 October 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources